Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMDA to Start 2nd 5-Year Plan a Year Ahead of Schedule
January 22, 2007
- JGPMA Proposes New Drug Benefit System
January 22, 2007
- Reform of Review System a Top Priority for PFSB: Mr Takahashi
January 22, 2007
- MEDICAL DEVICE NEWS IN BRIEF
January 22, 2007
- REGULATORY NEWS IN BRIEF ―２―
January 15, 2007
- FY2007 Draft Budget Includes \68.8 Bil. to Promote Life Science R&D: MEXT
January 15, 2007
- Next Clinical Trial Promotion Plan to Be Announced By End of March
January 15, 2007
- UK DOH's Expert Group Issues Recommendations on First-in-man Trials of High-risk Agents
January 15, 2007
- R&D NEWS IN BRIEF
January 15, 2007
- 10 Questions for the New Year
January 15, 2007
- Asymptomatic Hepatitis B 57% : Bristol-Myers
January 15, 2007
- Seminar
January 15, 2007
- Korosho to Initiate "Purity Testing" Project for Generics
January 15, 2007
- Blopress Remains Top Selling Drug for 3rd Year in a Row
January 15, 2007
- GENERIC NEWS IN BRIEF
January 15, 2007
- BUSINESS NEWS IN BRIEF
January 15, 2007
- OPINION
January 15, 2007
- Burgeoning Market for ARBs -Hot Battlefield for Megapharmas-
January 15, 2007
- Constipation Does Not Increase Risk of Colorectal Cancer: Korosho Study Group
January 15, 2007
- Korosho Committed to Promoting Innovation in Pharma Industry: Health Minister
January 15, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…